Related Experiment Video
Updated: Apr 30, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
454
Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
Tieqin Liu1, Hongxu Liu, Yu Li
1Department of Thoracic Surgery, First Hospital, China Medical University, Shenyang, China.
Asia-Pacific Journal of Clinical Oncology
|May 3, 2014
Summary
Systematic lymph node dissection is recommended for small non-small cell lung cancer (NSCLC) patients. Survival rates are significantly impacted by nodal involvement, disease stage, and surgical method, underscoring the importance of thorough nodal assessment.
Area of Science:
- Thoracic Surgery
- Oncology
- Pulmonary Medicine
Background:
- Computed tomography advancements have increased surgical interventions for small lung cancers.
- The necessity of systematic lymph node dissection in these cases remains debated.
Purpose of the Study:
- To evaluate the impact of lymph node involvement, disease stage, and surgical approach on survival rates in patients with small non-small cell lung cancer (NSCLC).
- To determine the optimal surgical strategy, including lymph node dissection, for T1a NSCLC.
Main Methods:
- Retrospective analysis of 138 patients with NSCLC (≤2 cm) operated on between 2004 and 2010.
- Kaplan-Meier survival analysis and log-rank tests were used to compare outcomes based on surgical approach, nodal status, histology, and survival rates.
Main Results:
- Lymph node metastasis was identified in 17% of patients.
- 5-year survival rates were 83% for node-negative, 75% for pN1, and 48% for pN2 disease (P=0.001).
- Lobectomy demonstrated significantly better survival than limited resection (P=0.02).
Conclusions:
- Patient survival in small lung cancer is strongly correlated with nodal status, disease stage, and surgical strategy.
- Systematic lymph node dissection is supported for patients diagnosed with T1a NSCLC.
